Autolus Therapeutics (AUTL) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Autolus Therapeutics (AUTL) over the last 6 years, with Q3 2025 value amounting to -$0.3.
- Autolus Therapeutics' EPS (Weighted Average and Diluted) rose 322.58% to -$0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.83, marking a year-over-year increase of 3196.72%. This contributed to the annual value of -$0.86 for FY2024, which is 2793.37% up from last year.
- Per Autolus Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.3 for Q3 2025, which was up 322.58% from -$0.18 recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' EPS (Weighted Average and Diluted) registered a high of $0.53 during Q1 2021, and its lowest value of -$466.29 during Q3 2021.
- In the last 5 years, Autolus Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.26 in 2023 and averaged -$24.9.
- As far as peak fluctuations go, Autolus Therapeutics' EPS (Weighted Average and Diluted) skyrocketed by 10000.18% in 2021, and later plummeted by 19787.23% in 2022.
- Over the past 5 years, Autolus Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$3.43 in 2021, then skyrocketed by 93.29% to -$0.23 in 2022, then plummeted by 95.65% to -$0.45 in 2023, then skyrocketed by 75.96% to -$0.11 in 2024, then plummeted by 177.29% to -$0.3 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.3 in Q3 2025, compared to -$0.18 in Q2 2025 and -$0.26 in Q1 2025.